Onkologie. 2011:5(2):106-109

Some complications of secondary lymphedema in women with malignant tumours - four cases and their treatment

Věra Vítová1,2, Hana Vítová1,3, Drahoslava Hrubá2
1 Ambulance léčby lymfedému, Masarykův onkologický ústav, Brno
2 Ústav preventivního lékařství LF MU Brno
3 DR CČSH Praha

The authors describe some complications of secondary lymphedema after malignant tumours treatement in women including their

therapy. There are frequent complications: infections (recurrent erysipelas, herpes zoster), primary tumour progressions and metastases,

hand-foot syndrome as a side-effect of chemotherapy and relatively rare complications e.g. second primary malignancy (lymphangiosarcoma

in lymphedema patients) as well as multiple malignancies. The authors found autoimmune thyroiditis and decreased thyroid

function in a patient treated for postmastectomy lymphedema.

Keywords: postmastectomy lymphedema, multiple malignancies, erysipelas

Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítová V, Vítová H, Hrubá D. Some complications of secondary lymphedema in women with malignant tumours - four cases and their treatment. Onkologie. 2011;5(2):106-109.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vojáčková N, Šipulová L, Hercogová J. Lymfedém. Klasifikace, diferenciální diagnostika a léčba. Postgraduální medicína 2008; 10(8): 850-853.
    2. Wald M, Křížová H, Prausová J, Adámek J. Sekundární lymfedém po lymfadenectomiích. Praktický lékař, 1999; 79(12): 666-669.
    3. Cozen W, Bernstein L, Wang F. The risk of angiosarcoma following primary breast cancer. British Journal of Cancer 1999; 81(3): 532-536. Go to original source... Go to PubMed...
    4. Vlčková J. Léčba lymfedému, vztahujícímu se ke karcinomu prsu. AGEL ACADEMY 2009; 3(1): 36-40.
    5. Navrátilová Z. Péče o kůži. Kožní komplikace lymfedému (diagnostika, léčba, prevence), In: Benda K, Bendová M, Cagášková J a kolektiv. Lymfedém - komplexní fyzioterapie, lymfodrenáže a doplňující léčebná péče. NCO NZO. Brno: 2007: 77-80.
    6. Benda K, Bendová M. Kvalitní spolupráce pacienta - významný faktor v léčbě lymfedému. Prakt. flebol. 2008; 17: 59.
    7. Miňovská V. Palmoplantární erytrodysestezie vyvolaná liposomálním doxorubicinem. Čes.-slov. Derm. 2003; 78(4): 159-161.
    8. Vítová V, Vítová H. Naše zkušenosti s léčbou lymfedému provázeného erytémem. Prakt. flebol. 2009; 18: 39-40.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.